JB

Jayprakash Bhagwant Gawande

Active Director Director DIN 07071264
DIN 07071264 First appointment Apr 2015 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayprakash Bhagwant Gawande

Data last updated:

Jayprakash Bhagwant Gawande is a Director at Muheal Healthcare Private Limited (since 2015). The company operates in Healthcare.

DIN 07071264
Primary Designation Director
Industry Healthcare
First Appointment 24 Apr 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Muheal Healthcare Private Limited U85190MH2015PTC263783
Director24 Apr 20152015Active

Board colleagues of Jayprakash Bhagwant Gawande

NameDINCompanyDesignation
Kiran Dubey07071270Muheal Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Muheal Healthcare Private Limited
Premium access

Shareholding and investment profile for Jayprakash Bhagwant Gawande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayprakash Bhagwant Gawande

Jayprakash Bhagwant Gawande currently holds 1 directorship: Muheal Healthcare Private Limited (Director, since 24 Apr 2015).

Jayprakash Bhagwant Gawande was first appointed on 24 Apr 2015 as Director at Muheal Healthcare Private Limited.

The current boards of Jayprakash Bhagwant Gawande's companies include Kiran Dubey (Muheal Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available